Skip to main content
. 2023 Nov 14;15(11):2623. doi: 10.3390/pharmaceutics15112623

Figure 1.

Figure 1

The general illustration of biomimetic delivery systems (BDSs). BDSs are designed to emulate natural structures, thereby augmenting therapeutic efficacy. Notable examples encompass liposomes, protein-based nanoparticles (PNPs), extracellular vesicles (EVs), cell membrane-derived nanocarriers (CMDNs), nanodiscs, and polysaccharides.